RSS

IONTAS

IONTAS, a company focused on the discovery and optimisation of fully human antibodies, has signed a collaboration agreement with Korean-based LG Chem to identify therapeutic oncology leads. more

News

Biotechnology company focused on the discovery and optimisation of fully human antibodies, IONTAS, has been awarded a major grant to support ongoing research into its novel antibody platform, KnotBody. more

News

Company focused on the discovery and optimisation of fully human antibodies, IONTAS, and a private biopharmaceutical company, aTen Therapeutics, have announced a collaboration for the discovery of therapeutic oncology leads. more

News

A collaboration between IONTAS, a company focused on the discovery and optimisation of fully human antibodies, and IGEM Therapeutics, an immunologist-oncology company, for the identification of novel IgE antibodies for cancer targets. more

News